Effect of glargine insulin on hyperglycemic control in type II diabetic patients

Phase 3

• Conditions: Condition 1: Type II diabetic. Condition 2: Cardiovascular disease.; Type 2 diabetes mellitus; Chronic ischaemic heart disease

• Registration Number: IRCT20130428013159N12
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age of 35-65 years
Sustaining ASA II
Blood sugar of 150-350 mg/dl
Lack of a simultaneous emergency surgery or heart valve surgery

Exclusion Criteria

Having underlying diseases (e.g., pulmonary, liver, kidney, thyroid, and digestive diseases)
Having history of open-heart surgery
Fever
Trauma
Carotid artery involvement
Sensitivity to insulin glargine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose. Timepoint: Before the surgery, every 2 hours intraoperatively, and every 4-24 hours after the surgery. Method of measurement: Glucose meter.

Secondary Outcome Measures

Name	Time	Method
ong hospital days in ICU. Timepoint: After intervention. Method of measurement: The questionnaire.;Type of antibiotic used. Timepoint: After intervention. Method of measurement: The questionnaire.;Wound dehiscence. Timepoint: After intervention. Method of measurement: The questionnaire.